Shenzhen Neptunus Interlong Bio-technique Company Limited (Neptunus Interlong) disclosed a supplemental profit-warning announcement, indicating an expected net loss attributable to shareholders of approximately RMB40.00 million for the financial year ended 31 December 2025.
The projected loss contrasts sharply with the RMB25.00 million net profit recorded in 2024, marking a year-on-year deterioration of roughly RMB65.00 million. Management attributed the downturn to factors previously outlined in announcements dated 10 and 20 March 2026.
Final audited figures will be released in the 2025 annual results, scheduled for publication on 25 March 2026. The board advised shareholders and potential investors to exercise caution when dealing in the company’s shares pending the full results release.
Comments